Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

FDA Approves Triple Therapy Polypill for High Blood Pressure

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

Polypills Show Promise in Diverse Hypertensive Patient Groups

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

August 31, 2024

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

News Daily News

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

Michael O'Riordan

July 27, 2021

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

October 23, 2019

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

News Daily News

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Michael O'Riordan

October 18, 2019

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

News Daily News

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

August 15, 2018

Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure

News Conference News ACC 2018

Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure

March 12, 2018

News Daily News

El Bloqueador de la Angiotensina Preserva la Función Endotelial Mejor que el Antagonista del Calcio

March 05, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

March 05, 2012

Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary DES Implantation in Hypertensive Patients

Presentation

Protective Effect of Telmisartan Against Endothelial Dysfunction After Coronary DES Implantation in Hypertensive Patients

Presenter: Mitsuyasu Terashima

February 29, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.